Brief: Starpharma Holdings Signs Agreement For Viraleze Nasal Spray In Saudi Arabia And 8 Other Countries
03/02/2022 01:17
Feb 3 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* SIGNED EXCLUSIVE SALES AND DISTRIBUTION AGREEMENT FOR
VIRALEZE
ANTIVIRAL NASAL SPRAY IN SAUDI ARABIA AND 8 OTHER COUNTRIES
Source text for Eikon: ID:nASXbmdtLn
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising